NCT01865721View on ClinicalTrials.gov

Optimizing the Use of Entonox® During Screening Colonoscopy

PHASE4CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

April 30, 2014

Study Completion Date

April 30, 2014

Conditions
Bowel Cancer ScreeningAnalgesiaEntonoxColonoscopy
Interventions
DRUG

Entonox

Entonox will be used according to the allocated method

Trial Locations (1)

S5 7AU

Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield

All Listed Sponsors
lead

Sheffield Teaching Hospitals NHS Foundation Trust

OTHER

NCT01865721 - Optimizing the Use of Entonox® During Screening Colonoscopy | Biotech Hunter | Biotech Hunter